SG Americas Securities’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-359,100
Closed -$1.6M 3565
2019
Q3
$1.6M Buy
359,100
+300,000
+508% +$28.5M 0.01% 1110
2019
Q2
$61K Sell
59,100
-16,700
-22% -$1.59M ﹤0.01% 2884
2019
Q1
$387K Sell
75,800
-118,200
-61% -$10.3M ﹤0.01% 2059
2018
Q4
$69K Buy
194,000
+17,500
+10% +$1.29M ﹤0.01% 2787
2018
Q3
$104K Sell
176,500
-25,000
-12% -$2.21M ﹤0.01% 2859
2018
Q2
$261K Sell
201,500
-32,700
-14% -$2.72M ﹤0.01% 2432
2018
Q1
$301K Sell
234,200
-83,200
-26% -$7.99M ﹤0.01% 2176
2017
Q4
$481K Sell
317,400
-148,300
-32% -$16.7M ﹤0.01% 1883
2017
Q3
$4.14M Buy
465,700
+87,100
+23% +$11.9M 0.04% 414
2017
Q2
$2.15M Buy
378,600
+156,000
+70% +$19.1M 0.02% 847
2017
Q1
$1.68M Buy
222,600
+84,500
+61% +$10.1M 0.01% 1002
2016
Q4
$937K Buy
138,100
+80,700
+141% +$8.99M 0.01% 1341
2016
Q3
$254K Hold
57,400
﹤0.01% 2290
2016
Q2
$250K Sell
57,400
-43,300
-43% -$4.48M ﹤0.01% 2011
2016
Q1
$139K Sell
100,700
-35,400
-26% -$3.65M ﹤0.01% 2427
2015
Q4
$155K Buy
+136,100
New +$15.7M ﹤0.01% 2225
2015
Q3
Sell
-112,800
Closed -$493K 3083
2015
Q2
$493K Buy
112,800
+102,400
+985% +$11.7M ﹤0.01% 1455
2015
Q1
$52K Buy
+10,400
New +$1.24M ﹤0.01% 2362
2014
Q1
Sell
-16,000
Closed -$269K 3061
2013
Q4
$269K Sell
16,000
-56,800
-78% -$4.49M ﹤0.01% 1911
2013
Q3
$291K Buy
72,800
+22,400
+44% +$1.57M ﹤0.01% 1936
2013
Q2
$62K Buy
+50,400
New +$3.03M ﹤0.01% 2161

Other funds holding CELG

SG Americas Securities's CELG Position: Q4 2019 in Review

SG Americas Securities sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 60,558 shares — an estimated $6.01M sold.

SG Americas Securities first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $221M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • SG Americas Securities reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • SG Americas Securities sold 60,558 Celgene Corp shares in Q4 2019, an estimated $6.01M.
  • SG Americas Securities first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • SG Americas Securities's Celgene Corp position peaked at $221M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on SG Americas Securities's 13F filing for Q4 2019, filed 28 Jan 2020.